<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20130811014330N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-11-29</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Effectiveness of hyaluronic acid for the treatment of interstitial cystitis</public_title>
      <acronym></acronym>
      <scientific_title>Treatment of interstitial cystitis; clinical effectiveness of hydrodistention with intravesical hyaluronic acid (cystistat®) over hydrodistention alone</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-04-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>24</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/34300</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization was used.patients were assigned to intervention and control groups using random assignment list generated by PASS software, Blinding description: In this study, the patients and the doctor were aware of the allocated treatment, so blinding was not possible. but the researcher who evaluated the questionnaires and the statistical analyst of the study were completely unaware about the treatment of each patient.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Interstitial cystitis / bladder pain syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Patients were provided with instructions needed before hydrodistention and told not to use a diet that exacerbates interstitial cystitis symptoms. If urinary tract infection was diagnosed, the patient was treated with antibiotics for a week. Hydrodistention was performed under general anesthesia. at first, a urologist performed cystoscopy. The bladder was dilated with normal sterile saline for 1-2 minutes. Then the bladder was emptied and refilled to allow the urologist to see the lesions and wounds perfectly. Therapeutic Hydrodistention was continued for another 8 minutes. In the 12 patients of the intervention group, Cystistat® solution (40mg of sodium hyaluronate in a 50ml vial) produced by Mylan company was infused into the bladder through a catheter. patients had to keep the solution in their bladder for at least 30 minutes and place in different positions, then drained it by urinating. This procedure was done weekly for four weeks, then monthly until two months later. Intervention 2: Control group: The 12 patients of the control group were provided with instructions needed before hydrodistention and told not to use a diet that exacerbates interstitial cystitis symptoms. If urinary tract infection was diagnosed, the patient was treated with antibiotics for a week. Hydrodistention was performed under general anesthesia. at first, a urologist performed cystoscopy. The bladder was dilated with normal sterile saline for 1-2 minutes. Then the bladder was emptied and refilled to allow the urologist to see the lesions and wounds perfectly. Therapeutic Hydrodistention was continued for another 8 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is "There is no further information"</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hamidreza Rahimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Medicine, Mashhad University of Medical Sciences, Azadi Square, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913316</zip>
        <telephone>+98 51 3800 2301</telephone>
        <email>rahimihr@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hamidreza Rahimi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Medicine, Mashhad University of Medical Sciences, Azadi Square, Mashhad, Iran</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913316</zip>
        <telephone>+98 51 3800 2301</telephone>
        <email>rahimihr@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Older than 18 years’ old
Previously treated with a daily 25 mg of Amitriptyline for at least 1 month, and did not show any improvement in symptoms.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of bacterial cystitis in the last 3 months
History of active genital herpes
History of vaginal cervical or uterine cancer
History of diverticulum
History of cyclophosphamide consumption
History of bladder tuberculosis
History of abdomen or pelvis radiotherapy
Vaginitis symptoms
History of bladder stones
History of symptom relief with antimicrobials or anticholinergics
Frequency of urination less than 8 times a day
History of benign or malignant bladder tumors</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N30.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Interstitial cystitis (chronic)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Patients were provided with instructions needed before hydrodistention and told not to use a diet that exacerbates interstitial cystitis symptoms. If urinary tract infection was diagnosed, the patient was treated with antibiotics for a week. Hydrodistention was performed under general anesthesia. at first, a urologist performed cystoscopy. The bladder was dilated with normal sterile saline for 1-2 minutes. Then the bladder was emptied and refilled to allow the urologist to see the lesions and wounds perfectly. Therapeutic Hydrodistention was continued for another 8 minutes. In the 12 patients of the intervention group, Cystistat® solution (40mg of sodium hyaluronate in a 50ml vial) produced by Mylan company was infused into the bladder through a catheter. patients had to keep the solution in their bladder for at least 30 minutes and place in different positions, then drained it by urinating. This procedure was done weekly for four weeks, then monthly until two months later.</i_keyword>
      <i_keyword>Control group: The 12 patients of the control group were provided with instructions needed before hydrodistention and told not to use a diet that exacerbates interstitial cystitis symptoms. If urinary tract infection was diagnosed, the patient was treated with antibiotics for a week. Hydrodistention was performed under general anesthesia. at first, a urologist performed cystoscopy. The bladder was dilated with normal sterile saline for 1-2 minutes. Then the bladder was emptied and refilled to allow the urologist to see the lesions and wounds perfectly. Therapeutic Hydrodistention was continued for another 8 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Frequency of urination. Timepoint: Baseline, 1 week, 1 month, and 3 months after intervention. Method of measurement: the O`Leary-Sant questionnaire.</prim_outcome>
      <prim_outcome>Urgency. Timepoint: Baseline, 1 week, 1 month, and 3 months after intervention. Method of measurement: the O`Leary-Sant questionnaire.</prim_outcome>
      <prim_outcome>Nocturia. Timepoint: Baseline, 1 week, 1 month, and 3 months after intervention. Method of measurement: the O`Leary-Sant questionnaire.</prim_outcome>
      <prim_outcome>Dysuria. Timepoint: Baseline, 1 week, 1 month, and 3 months after intervention. Method of measurement: the O`Leary-Sant questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-12-21</approval_date>
        <contact_name>Ethics Committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Faculty of Medicine, University Campus, Azadi Square Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
